Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Antizyme slows skin tumor growth by reducing cell growth in mice.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

JAK inhibitors show promise for treating various skin diseases.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

A new compound effectively inhibits human 5α-reductase 1.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.